NASDAQ
25.70USD
-0.54 (-2.07%)
We have scored 15 news catalysts on Progyny, Inc. (PGNY) over the past 12 months. The biggest single-day move next to one of them came Nov 7, 2025, when PGNY closed +24.2%: “Why Progyny Stock Is Soaring Today”. Coverage across the window leans positive (average ticker sentiment +0.62). Most of the impact sits in sector healthcare and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
2B
P/E
—
EPS
—
Beta
0.99
52W range
16.1-33.065
Day range
25.64–26.42
Open
26.10
Prev close
26.24
Volume
672.1K
Avg volume
1.3M
Dividend
0.00
IPO
2019-10-25
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Progyny, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for PGNY: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
